CD8A and neoplasm: Additionally, CD8+CD161+ T-cells demonstrated lower expression of exhaustion markers, LAG-3 (p = 3E-7), TIM-3 (p = 0.05), and PD-1 (p = 3E-7), pointing towards a more robust and sustained anti-tumor response (Figure 3D).